Search - tctmd.com

Displaying 441 - 460 of 1387

Sort: Relevancy | Date

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

L.A. McKeown

November 01, 2022

News Daily News

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

Caitlin E. Cox

October 27, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Daily News

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Yael L. Maxwell

September 29, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

Presentation TCT 2022

BPA for CTEPH: When and How?

Presenter: Vikas Aggarwal

September 19, 2022

Presentation TCT 2022

CTEPH? CTED? How Do We Make the Diagnosis?

Presenter: Riyaz Bashir

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2022

Novel Approaches to Assess Hypertension Control Outside the Office

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Presenter: Melvin Lobo

September 17, 2022

Presentation TCT 2022

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Presenter: Debbie Cohen

September 17, 2022

Advertisement

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

SCAD in Men: Canadian Study Sheds Light on Rare Condition

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

BPA for CTEPH: When and How?

CTEPH? CTED? How Do We Make the Diagnosis?

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Novel Approaches to Assess Hypertension Control Outside the Office

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content